December 10, 2020 – The 2020 A4M Pain and Cannabinoid Medicine Update will be a virtual event that typically is hosted annually in Las Vegas. Dr Joseph Maroon is the Senior VP of the American Academy of Anti-Aging Medicine and has been asked to present on the Neurological Uses for Cannabis and CBD.
Numerous physical, psychological and emotional benefits have been attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia. The phytocannabinoids, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (Δ9-THC), are the most studied extracts from cannabis sativa subspecies hemp and marijuana. CBD and Δ9-THC interact uniquely with the endocannabinoid system (ECS). Through direct and indirect actions, intrinsic endocannabinoids and plant-based phytocannabinoids, modulate and influence a variety of physiological systems influenced by the ECS.
Neurological applications are now the major focus of renewed research using medical marijuana and phytocannabinoid extracts. Recent neurological uses include adjunctive treatment for malignant brain tumors, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, neuropathic pain, and the childhood seizure disorders Lennox-Gastaut and Dravet Syndromes. In addition, psychiatric and mood disorders, such as schizophrenia, anxiety, depression, addiction, post-concussion syndrome and post-traumatic stress disorders are being studied using phytocannabinoids.
Hear a Preview of the Upcoming Lecture by Dr Maroon – HERE